Amy Sater to Neuroblastoma
This is a "connection" page, showing publications Amy Sater has written about Neuroblastoma.
Connection Strength
0.709
-
Molecular targeting therapies for neuroblastoma: Progress and challenges. Med Res Rev. 2021 03; 41(2):961-1021.
Score: 0.356
-
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope. Cancer Lett. 2021 01 01; 496:16-29.
Score: 0.353